Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Tóm tắt
Từ khóa
Tài liệu tham khảo
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 73 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2
Gupta, 2020, Clinical considerations for patients with diabetes in times of COVID-19 epidemic, Diabetes Metab Syndr, 14, 211, 10.1016/j.dsx.2020.03.002
Akbar, 2001, Bacterial pneumonia: comparison between diabetics and non-dia-betics, Acta Diabetol, 38, 77, 10.1007/s005920170017
Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabet Med, 23, 623, 10.1111/j.1464-5491.2006.01861.x
Allard, 2010, Diabetes and the severity of pandemic influenza A (H1N1) infection, Diabetes Care, 33, 1491, 10.2337/dc09-2215
Badawi, 2016, Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis, Int J Infect Dis, 49, 129, 10.1016/j.ijid.2016.06.015
Al-Tawfiq, 2014, Middle East respiratory syndrome coronavirus: a case–control study of hospitalized patients, Clin Infect Dis, 59, 160, 10.1093/cid/ciu226
Alraddadi, 2016, Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia 2014 Emerg Infect Dis, 22, 49
Singh, 2020, Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers, Diabetes Metabol Syndrome Res Rev
Yang, 2020, Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int J Infect Dis, 10.1016/j.ijid.2020.03.017
Epidemiology Working Group for Ncip Epidemic Response, 2020, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, Chin J Epidemiol, 41, 145
Onder, 2020, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, J Am Med Assoc, 10.1001/jama.2020.4683
Bhatraju, 2020, Covid-19 in critically ill patients in the seattle region — case series, NEJM.org, 10.1056/NEJMoa2004500
Covid-19 surveillance group, Italy
Liu
Guan
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5
Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7
Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in wuhan, China, J Am Med Assoc, 323, 1061, 10.1001/jama.2020.1585
Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Published Online March, 9
Zhang, 2020, Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China, Allergy, 10.1111/all.14238
Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 10.1016/S2213-2600(20)30079-5
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China. JAMA Intern Med. Published online March 13, 2020. doi:10.1001/jamainternmed.2020.0994 (Accessed on March 31, 2020)
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017. Published online March 31, 2020.
Liu, 2020, Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province, Chin Med J
Chen, 2020, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ, 368, m109
Chen
Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, J Am Med Assoc, 10.1001/jama.2020.2648
Wang
Vaduganathan, 2020, Renin–angiotensin–aldosterone system inhibitors in patients with covid-19, N Engl J Med, 10.1056/NEJMsr2005760
Hoffmann, 2020, The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells, bioRxiv, 2020
Chen, 2020, Hypertension and diabetes delay the viral clearance in COVID-19 patients, medRxiv, 2020
Roca-Ho, 2017, Characterization of ACE and ACE2 287 expression within different organs of the NOD mouse, Int J Mol Sci, 18, 10.3390/ijms18030563
Rao S, Lau A, and So H-C. Exploring diseases/traits and blood proteins causally related to 284 expression of ACE2, the putative receptor of 2019-nCov: a Mendelian Randomization analysis. vol. 285 medRxiv: 2020.2003.2004.20031237, 2020.
Fernandez, 2018, Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality, J Intern Med, 284, 377, 10.1111/joim.12783
Kulcsar, 2019, Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection, JCI Insight, 4, 131774, 10.1172/jci.insight.131774
Maddaloni, 2020, Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics, Diabetes Metab Res Rev, 10.1002/dmrr.3321
2020
Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4
Kajiwara, 2018, Metformin mediates protection against Legionella pneumonia through activation of AMPK and mitochondrial reactive oxygen species, J Immunol, 200, 623, 10.4049/jimmunol.1700474
Zhang, 2020, Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis, Eur J Clin Pharmacol, 76, 149, 10.1007/s00228-019-02786-y
Mendy, 2019, Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin, Respirology, 24, 646, 10.1111/resp.13486
Ho, 2019, Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease, Respir Res, 20, 69, 10.1186/s12931-019-1035-9
Gorricho, 2017, Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study, Br J Clin Pharmacol, 83, 2034, 10.1111/bcp.13288
Zhang, 2014, Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis, Sci World J, 2014, 603409
Romaní-Pérez, 2015, Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats, Endocrinology, 156, 3559, 10.1210/en.2014-1685
Mentlein, 1999, Dipeptidyl-peptidase IV (CD26)–role in the inactivation of regulatory peptides, Regul Pept, 85, 9, 10.1016/S0167-0115(99)00089-0
Gierer, 2013, The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies, J Virol, 87, 5502, 10.1128/JVI.00128-13
Qian, 2013, Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation, PloS One, 8, 10.1371/journal.pone.0076469
Kleine-Weber, 2020, Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus, Emerg Microb Infect, 9, 155, 10.1080/22221751.2020.1713705
Raj, 2013, Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC, Nature, 495, 251, 10.1038/nature12005
Vankadari, 2020, Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerg Microb Infect, 9, 601, 10.1080/22221751.2020.1739565
Jackson, 2008, Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure, Clin Exp Pharmacol Physiol, 35, 29, 10.1111/j.1440-1681.2007.04737.x
Marney, 2010, Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans, Hypertension, 56, 728, 10.1161/HYPERTENSIONAHA.110.156554
Devin, 2014, Substance P increases sympathetic activity during combined angiotensin converting enzyme and dipeptidyl peptidase-4 inhibition, Hypertension, 63, 951, 10.1161/HYPERTENSIONAHA.113.02767
Brown, 2009, DPP-4 inhibitors use associated with increased risk of ACE-inhibitors associated angioedema, Hypertension, 54, 516, 10.1161/HYPERTENSIONAHA.109.134197
Abouelkheir, 2019, Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme, Eur J Pharmacol, 862, 172638, 10.1016/j.ejphar.2019.172638
Iacobellis, 2020, COVID-19 and Diabetes: can DPP4 inhibition play a role?, Diabetes Res Clin Pract, 108125, 10.1016/j.diabres.2020.108125
Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabet Med, 23, 623, 10.1111/j.1464-5491.2006.01861.x
Badawi, 2016, Prevalence of diabetes in the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta-analysis, J Public Health Res, 5, 733
Razavi, 2018, Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients, Endocrine, 61, 267, 10.1007/s12020-018-1635-z
Tran, 2019, Intravenous insulin infusion protocol compared with subcutaneous insulin for the management of hyperglycemia in critically ill adults, Ann Pharmacother, 53, 894, 10.1177/1060028019841363
Bhurayanontachai, 2018, Comparison of glycemic control between continuous regular insulin infusion and single-dose subcutaneous insulin glargine injection in medical critically ill patients, Indian J Crit Care Med, 22, 174, 10.4103/ijccm.IJCCM_273_17
Lee, 2004, Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy, Crit Care Nurs Q, 27, 172, 10.1097/00002727-200404000-00009
Leelarathna, 2013, Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial, Crit Care, 17, R159, 10.1186/cc12838
Basu, 2017, Continuous glucose monitor interference with commonly prescribed medications: a pilot study, J Diabetes Sci Technol, 11, 936, 10.1177/1932296817697329
Schuster, 2014, Continuous glucose monitoring in the surgical intensive care unit: concordance with capillary glucose, J Trauma Acute Care Surg, 76, 798, 10.1097/TA.0000000000000127
Li, 2017, The vasoprotective axes of the renin-angiotensin system:physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases, Pharmacol Res, 125, 21, 10.1016/j.phrs.2017.06.005
Yang, 2014, Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury, Sci Rep, 4, 7027, 10.1038/srep07027
Henry, 2018, Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia, SAVE Proc, 31, 419
Peng, 2020, Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV, Zhonghua Xinxueguanbing Zazhi, 48
2020
Batais, 2017, The use of statins and risk of community-acquired pneumonia, Curr Infect Dis Rep, 19, 26, 10.1007/s11908-017-0581-x
Fedson, 2020, Hiding in plain sight: an approach to treating patients with severe COVID-19 infection, mBio, 11, 10.1128/mBio.00398-20
Yuan, 2015, Statins may decrease the fatality rate of Middle East respiratory syndrome infection, mBio, 6, 10.1128/mBio.01120-15
Zheng, 2017, Preadmission use of calcium channel blockers and outcomes after hospitalization with pneumonia: a retrospective propensity-matched cohort study, Am J Therapeut, 24, e30, 10.1097/MJT.0000000000000312
Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 10.1016/S2213-2600(20)30116-8